Evercore ISI Increases Becton, Dickinson and Company (NYSE:BDX) Price Target to $290.00

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price objective boosted by Evercore ISI from $286.00 to $290.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s target price would indicate a potential upside of 20.95% […]

Leave a Reply

Your email address will not be published.

Previous post Chord Energy (NASDAQ:CHRD) PT Lowered to $185.00
Next post Citigroup Lowers Integra LifeSciences (NASDAQ:IART) Price Target to $16.00